Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 8/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
| ▸ | CTSB | P07858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9967725 | 0.79 | NFE2L2 (0.55) | NFE2L2PTGS1PTGS2HTR2AHTR2C | |
| SCHEMBL25734851 | 0.75 | NFE2L2 (0.34) | NFE2L2PTGS1PTGS2 | |
| SCHEMBL26759558 | 0.68 | NFE2L2 (0.34) | NFE2L2PTGS1PTGS2 | |
| SCHEMBL4905475 | 0.68 | NFE2L2 (0.54) | NFE2L2PTGS1PTGS2HTR2AHTR2C | |
| SCHEMBL14748246 | 0.68 | NFE2L2 (0.54) | NFE2L2 | |
| SCHEMBL25937842 | 0.67 | NFE2L2 (0.43) | NFE2L2PTGS2 | |
| SCHEMBL105258 | 0.66 | NFE2L2 (0.54) | NFE2L2PTGS1PTGS2LMNAHPGD | |
| SCHEMBL2869906 | 0.66 | NFE2L2 (0.54) | NFE2L2PTGS1PTGS2LMNAHPGD | |
| SCHEMBL9967767 | 0.66 | APLNR (0.38) | NFE2L2PTGS1PTGS2LMNA | |
| SCHEMBL9967763 | 0.66 | NFE2L2 (0.37) | NFE2L2PTGS1PTGS2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | C1S, CCNT1, C9 | NFE2L2 171/4885PTGS1 1011/4885PTGS2 2054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.